"Lupus Nephritis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).
Descriptor ID |
D008181
|
MeSH Number(s) |
C12.777.419.570.363.680 C13.351.968.419.570.363.680 C17.300.480.680 C20.111.590.560
|
Concept/Terms |
Lupus Nephritis- Lupus Nephritis
- Lupus Glomerulonephritis
- Nephritis, Lupus
- Lupus Nephritides
- Nephritides, Lupus
- Glomerulonephritis, Lupus
- Glomerulonephritides, Lupus
- Lupus Glomerulonephritides
|
Below are MeSH descriptors whose meaning is more general than "Lupus Nephritis".
Below are MeSH descriptors whose meaning is more specific than "Lupus Nephritis".
This graph shows the total number of publications written about "Lupus Nephritis" by people in this website by year, and whether "Lupus Nephritis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1998 | 0 | 2 | 2 |
2002 | 2 | 0 | 2 |
2003 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2007 | 3 | 0 | 3 |
2008 | 2 | 1 | 3 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 3 | 0 | 3 |
2012 | 2 | 0 | 2 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 6 | 0 | 6 |
2016 | 3 | 0 | 3 |
2017 | 3 | 0 | 3 |
2019 | 2 | 1 | 3 |
2022 | 5 | 0 | 5 |
2023 | 3 | 0 | 3 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lupus Nephritis" by people in Profiles.
-
Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis. Pediatr Nephrol. 2024 Oct; 39(10):2959-2968.
-
Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis. Arthritis Rheumatol. 2024 Mar; 76(3):469-478.
-
Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum. J Autoimmun. 2024 01; 142:103134.
-
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus. Front Immunol. 2023; 14:1217121.
-
Urine L-selectin reflects clinical and histological renal disease activity and treatment response in lupus nephritis across multi-ethnicity. Front Immunol. 2023; 14:1200167.
-
Molecular architecture of proliferative lupus nephritis as elucidated using 50-plex imaging mass cytometry proteomics. Clin Immunol. 2023 09; 254:109713.
-
Analytical validation of urine ALCAM ELISA as a test for lupus nephritis. Expert Rev Mol Diagn. 2023 Jul-Dec; 23(8):729-738.
-
V-Set Immunoglobulin Domain-Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity. Arthritis Rheumatol. 2023 09; 75(9):1573-1585.
-
Pathogenic cellular and molecular mediators in lupus nephritis. Nat Rev Nephrol. 2023 08; 19(8):491-508.
-
International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24?months. Pediatr Nephrol. 2023 11; 38(11):3699-3709.